Recent news on

Eisai Inc. Breaks Ground for New Oncology Facility in Research ...  -  Nov 24, 2006
Expansion Management,The new facility will complement the existing 190,000 square foot structure, which is devoted to manufacturing Aricept (donepezil hydrochloride tablets) and ...

Alzheimer's Disease :: Aricept - donepezil hydrochloride - for ...  Oct 16, 2006
The Food and Drug Administration (FDA) approved Aricept (donepezil hydrochloride) for the treatment of severe dementia in patients with Alzheimer's Disease. ... -SpiritIndia, Aricept Use Expanded to Severe Alzheimer's Dementia  Oct 13, 2006
13 (HealthDay News) -- Aricept (donepezil hydrochloride) has been approved by the US Food and Drug Administration to treat severe dementia associated with ... -Forbes, FDA Approves Expanded Use of Treatment for Patients With Severe ...  Oct 13, 2006
BETHESDA, MD -- October 13, 2006 -- The Food and Drug Administration (FDA) today approved Aricept (donepezil hydrochloride) for the treatment of severe ... -DG News FDA Approves Expanded Use of Treatment for Patients With Severe ...  Oct 16, 2006
The Food and Drug Administration (FDA) last Friday approved Aricept (donepezil hydrochloride) for the treatment of severe dementia in patients with Alzheimer's ... -eMaxHealth.com, FDA Approves Expanded Use of Treatment for Patients With Severe ...  Oct 17, 2006
The FDA has approved Aricept (donepezil hydrochloride) for the treatment of severe dementia in patients with Alzheimer's Disease. ... -Pharmaceutical Processing, FDA Approves Expanded Use of Treatment for Patients With Severe ...  Oct 16, 2006
16, 2006-The Food and Drug Administration (FDA) today approved Aricept (donepezil hydrochloride) for the treatment of severe dementia in patients with ... -PharmaLive.com (press release), Eisai Inc. Breaks Ground for New Oncology Facility in Research ...  -  Nov 24, 2006
Expansion Management,The new facility will complement the existing 190000 square foot structure, which is devoted to manufacturing Aricept (donepezil hydrochloride tablets) and

NICE Subject to Potential Judicial Review Following Unfair and ...  -  Nov 17, 2006
PharmaLive.com (press release),17, 2006-Eisai Limited, the licence holder of Aricept® (donepezil hydrochloride) and Pfizer Limited, its co-promotion partner, announced today that Eisai

Eisai Commences US Legal Action Over Aricept ODT(R) ANDA Filing  Aug 3, 2006
...of an abbreviated new drug application (ANDA) to the FDA for Aricept ODT® Orally Disintegrating Tablets (Active Ingredient Name: donepezil hydrochloride). ... -Yahoo! News

Pharmaceutical Company Files Lawsuit  Aug 4, 2006
Eisai claims that its patent related to the drug’s ingredient donepezil hydrochloride isn’t set to expire until November 2010. ... -Business New Jersey (subscription)

Eisai Commences US Legal Action Over Aricept ODT ANDA Filing  Aug 6, 2006
...drug application (ANDA) to the Food and Drug Administration (FDA) for Aricept ODT Orally Disintegrating Tablets (Active Ingredient Name: donepezil hydrochloride ... -ag-IP-news Agency

Teva/Eisai: the End of an Alliance  Jul 13, 2006
Eisai has an existing sales force for its Alzheimer's disease drug, Aricept (donepezil hydrochloride), and recently expanded the number of specialist sales ... -International News Service

Eisai Inc. Announces Appointment of Vice President of Business ...  Jul 6, 2006
...commercial infrastructure, and negotiating global alliances with, for example, Pfizer and Janssen for Aricept(R) (donepezil hydrochloride tablets) and Aciphex(R ... -PR Newswire



Eisai Will Initiate Phase I Study For E2012, A Potential New ...  May 11, 2006
As a leader in Alzheimer's disease therapy, in part through its marketed drug, ARICEPT (donepezil hydrochloride tablets), Eisai is pursuing a multi-faceted ... - Medical News Today

Eisai Will Initiate First Clinical Study for E2012, A Potential ...  May 9, 2006
As a leader in Alzheimer's disease therapy through its marketed product, Aricept (donepezil hydrochloride tablets) an acetylcholinesterase inhibitor, Eisai is ... - PharmaLive.com





Eisai Inc. and US Pharmacist Seek Nominations for Fifth Annual hhc ...  Mar 30, 2006
As the discoverer and developer of Aricept(R) (donepezil hydrochloride tablets), the number-one prescribed Alzheimer's medication worldwide, Eisai developed ... - PR Newswire

Oncology Pipeline Leads to New Eisai Inc. Research Triangle Park ...  Feb 27, 2006
2001." The existing facility encompasses approximately 190,000 square feet and is devoted to manufacturing Aricept(R) (donepezil hydrochloride tablets) and ... - PR Newswire,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional